The Limited Times

Now you can see non-English news...

Ema, possible links between the J&J vaccine and rare thrombosis

2021-04-20T15:38:42.388Z


The European Medicines Agency (EMA) recognizes "possible" cause-and-effect links between the Johnson & Johnson vaccine and the "very rare" events of cerebral thrombosis that have occurred in the US. (HANDLE)


(ANSA) - BRUSSELS, APRIL 20 - The European Medicines Agency (Ema) recognizes "possible" cause-and-effect links between the Johnson & Johnson vaccine and the "very rare" cerebral thrombosis events that occurred in the US.

This was stated in a note by Ema herself at the end of the serum review, after very rare cases of cerebral thrombosis in the United States, specifying however that "the benefits outweigh the risks".


    "The cases of rare events examined after the J & J vaccine are very similar to the cases that occurred with the Covid-19 vaccine developed by AstraZeneca", emphasizes the European Medicines Agency, specifying that all rare events of cerebral thrombosis "have occurred in people of less than 60 years of age within three weeks of vaccination "with Johnson & Johnson serum," the majority in women. Based on the evidence currently available - it is added -, the specific risk factors have not been confirmed.


    "The safety committee of the European Medicines Agency concluded that a warning about unusual blood clots with low platelets should be added to the information" in the leaflet "about the product for the Janssen vaccine," by Johnson & Johnson, "the release clarifies. - the events should be listed as very rare side effects of the vaccine ". (HANDLE).


Source: ansa

All life articles on 2021-04-20

You may like

Life/Entertain 2024-03-26T14:34:32.238Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.